Aflac Incorporated (NYSE:AFL) Shares Sold by Cozad Asset Management Inc.

Cozad Asset Management Inc. lessened its stake in Aflac Incorporated (NYSE:AFL) by 5.7% during the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 13,286 shares of the financial services provider’s stock after selling 797 shares during the period. Cozad Asset Management Inc.’s holdings in Aflac were worth $1,096,000 as of its most recent SEC filing.

Other institutional investors have also recently added to or reduced their stakes in the company. BKM Wealth Management LLC purchased a new stake in Aflac in the 4th quarter valued at approximately $1,558,000. abrdn plc boosted its holdings in Aflac by 51.2% in the 4th quarter. abrdn plc now owns 298,226 shares of the financial services provider’s stock valued at $24,604,000 after purchasing an additional 100,937 shares in the last quarter. J.W. Cole Advisors Inc. boosted its holdings in Aflac by 353.3% in the 4th quarter. J.W. Cole Advisors Inc. now owns 14,754 shares of the financial services provider’s stock valued at $1,217,000 after purchasing an additional 11,499 shares in the last quarter. Nordea Investment Management AB boosted its holdings in Aflac by 25.9% in the 4th quarter. Nordea Investment Management AB now owns 1,693,249 shares of the financial services provider’s stock valued at $139,676,000 after purchasing an additional 348,400 shares in the last quarter. Finally, G&S Capital LLC boosted its holdings in Aflac by 65.1% in the 4th quarter. G&S Capital LLC now owns 31,825 shares of the financial services provider’s stock valued at $2,626,000 after purchasing an additional 12,551 shares in the last quarter. Institutional investors and hedge funds own 67.44% of the company’s stock.

Aflac Price Performance

AFL stock opened at $83.64 on Wednesday. Aflac Incorporated has a 1 year low of $64.10 and a 1 year high of $86.26. The company has a debt-to-equity ratio of 0.33, a quick ratio of 0.06 and a current ratio of 0.06. The stock’s 50 day moving average price is $82.89 and its 200 day moving average price is $81.84. The firm has a market cap of $48.13 billion, a P/E ratio of 10.79, a PEG ratio of 2.29 and a beta of 0.91.

Aflac (NYSE:AFL) last posted its earnings results on Thursday, February 1st. The financial services provider reported $1.25 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $1.47 by ($0.22). Aflac had a net margin of 24.92% and a return on equity of 17.59%. The company had revenue of $3.78 billion during the quarter, compared to analysts’ expectations of $4.44 billion. During the same period in the previous year, the company posted $1.29 EPS. On average, sell-side analysts expect that Aflac Incorporated will post 6.41 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of equities research analysts have weighed in on the company. Raymond James lifted their price objective on Aflac from $83.00 to $88.00 and gave the company an “outperform” rating in a report on Friday, February 2nd. Morgan Stanley lifted their price objective on Aflac from $80.00 to $84.00 and gave the company an “equal weight” rating in a report on Monday, April 15th. Wells Fargo & Company decreased their price target on Aflac from $83.00 to $81.00 and set an “equal weight” rating on the stock in a research note on Thursday, April 11th. UBS Group boosted their price target on Aflac from $80.00 to $84.00 and gave the stock a “neutral” rating in a research note on Wednesday, January 10th. Finally, Evercore ISI lowered Aflac from an “in-line” rating to an “underperform” rating and boosted their price target for the stock from $76.00 to $78.00 in a research note on Thursday, January 4th. Three investment analysts have rated the stock with a sell rating, eight have issued a hold rating and three have issued a buy rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and an average price target of $82.15.

Insider Activity at Aflac

In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. In other Aflac news, Director Thomas J. Kenny sold 5,000 shares of the business’s stock in a transaction on Wednesday, March 20th. The stock was sold at an average price of $84.62, for a total value of $423,100.00. Following the completion of the transaction, the director now directly owns 17,920 shares in the company, valued at approximately $1,516,390.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, SVP Albert Riggieri sold 8,000 shares of the business’s stock in a transaction on Thursday, March 14th. The shares were sold at an average price of $83.34, for a total value of $666,720.00. Following the completion of the transaction, the senior vice president now owns 32,825 shares of the company’s stock, valued at $2,735,635.50. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 46,493 shares of company stock valued at $3,765,706. 0.80% of the stock is owned by corporate insiders.

About Aflac

Aflac Incorporated, through its subsidiaries, provides supplemental health and life insurance products. The company operates through Aflac Japan and Aflac U.S. segments. The Aflac Japan segment offers cancer, medical, nursing care, work leave, GIFT, and whole and term life insurance products, as well as WAYS and child endowment plans under saving type insurance products in Japan.